Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency
14/08/2026 06:01
BRIEF-Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency Aug 14 (Reuters) - Pfizer PFE.N:
PFIZER AND VALNEVA’S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
: PFIZER AND VALNEVA'S LYME DISEASE VACCINE CANDIDATE MARKETING AUTHORIZATION APPLICATION VALIDATED BY EUROPEAN MEDICINES AGENCY
Source text: ID:nGNXbcryXk
Further company coverage: VLS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pfizer
See all newsBrief: Enanta Pharmaceuticals In Patent Infringement Action Against Pfizer
Brief: Edison Scientific Announces Agreement With Pfizer To Accelerate Research And Development
Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge (updated)
Corrected: Bristol Myers raises 2026 revenue forecast, lowers EPS due to charge
Brief: Pfizer’S ELREXFIO Outperforms Standard Regimens And Meets Primary Endpoint In Phase 3 Study In Relapsed Or Refractory Multiple Myeloma